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Supplementary Note 1: Identification of cis-eQTLs and cis-pQTLs in osteoarthritis tissues 
To verify that the molQTL results were robust, we carried out a sensitivity analysis including 
patient age and osteoarthritis joint (knee or hip) as covariates in addition to the PEER 
factors, sex and array. In each tissue, ³89.8% of eGenes and >82% of pGenes significant in 
the main analysis also remained significant at 5% FDR in the sensitivity analysis, with a very 
strong correlation of normalized effect sizes reported for eGene and pGene variants 
identified across both analyses (Pearson r³0.988, P<10-15). 
 
We note that we detected a smaller proportion of genes with pQTLs (38 of 1,677 proteins in 
cartilage, 2.6%) than with eQTLs (1,569 of 15,249 in cartilage, 10.3%). Generally, protein 
expression is influenced by RNA levels as well as translational and post-translational 
mechanisms, so it is possible that the regulatory effects from genetic variants are 
diminished. A recent study of brain samples also found fewer genes with pQTLs than with 
eQTLs (14.7% versus 10.7% of 5,743 genes profiled on both assays)1. Moreover, differences 
in the detected numbers of eQTLs and pQTLs are also likely to be influenced by 
technological differences between the RNA sequencing and proteomics platforms. 
 
We investigated whether variants that are significant pQTLs also exhibit evidence of eQTL 
effects (Supplementary Fig. 3). In low-grade cartilage, we detected 2871 pQTL variants, of 
which 2866 were also present in the low-grade cartilage eQTL analysis. Of these variants, 
2577 (90%) have the same direction of effect on gene expression and protein levels, and 
1295 (50%) were also significant eQTLs in low-grade cartilage at 5% FDR. 
In high-grade cartilage, we detected 1971 pQTL variants, of which 1969 variants were also 
present in the high-grade eQTL analysis. Of these 1786 (91%) have the same direction of 
effect on gene expression and protein levels, and 1133 (63%) were also significant eQTLs in 
high-grade cartilage at 5% FDR. 
 
We carried out a protein-protein network analysis to identify known and potential 
connections between the 38 proteins with significant pQTLs identified in cartilage, using the 
STRING v11 database2 (https://string-db.org/). This identified 21 connections between the 
proteins (Supplementary Fig. 4). While this is significantly higher than the number of 
connections between 38 randomly selected proteins (STRING p=3.08x10-8), the formal 
network analysis does not account for the abundance level of proteins, which impacts the 
power to detect both pQTLs and functional interactions.  
 
 
Supplementary Note 2: Differential eQTLs between low-grade and high-grade cartilage 
Among 32 genes with differential eQTLs, 20 genes showed strong evidence for specific 
regulatory effects present in high-grade, but not low-grade cartilage; the remaining 12 
genes showed strong evidence for specific regulatory effects present in low-grade, but not 
high-grade cartilage. We tested whether the two groups differed in genes annotated to 
“regulation of gene expression”, “nervous system development”, “response to stress”, 
“immune response”, “cell adhesion” and “catabolic processes” (based on annotations from 
GoSeq and GeneCards, see Methods). We did not find any significant associations (Fisher’s 
test p>0.06), which could be due to a broader rewiring of regulatory processes (with some 
losses and some gains of genetic regulatory effects), and/or due to the small numbers of 
genes in the enrichment analysis. 
 
We also tested whether genes with differential eQTL were enriched in any GeneOntology 
annotations with 20-200 genes using GoSeq, compared to all 1569 gene with an eQTL in any 
cartilage tissue. We separately analysed all 32 genes, as well as 20 respectively 12 genes 
based on tissue with observed differential eQTL effect, restricting the analysis to genes with 
unique Ensembl gene ID, gene symbol and Entrez gene ID. Again, we did not detect any 
significant associations (FDR>5%).  
 
We note that this approach is simplified due to not accounting for several factors that 
influence the power to detect eQTLs, including the expression levels of genes, the number 
of SNPs within the gene region, their LD pattern and minor allele frequency. Given the 
limited power to detect associations based on a small number of genes, we have left more 
in-depth enrichment analyses of genes with differential eQTLs for future work based on 
larger sample sizes. 
 
Supplementary Note 3: Differential gene expression between high-grade and low-grade 
cartilage 
We compared the differential expression results between the 5 analysis designs as well as 5 
different tests (limma, DESeq2 with and without outlier filtering, edgeR likelihood ratio test 
and edgeR F test). For each analysis design, the number of significant genes at 5% FDR was 
similar across all tests:  
1) 7119-7487 genes for the paired analysis of intact and degraded samples (i.e. 
specifying patient ID as covariate); 
2) 5774-6126 genes for the paired analysis of intact and degraded samples, with 10 
additional covariates accounting for technical variation identified by SVAseq; 
3) 4005-4286 genes for the paired analysis of intact and degraded samples, with 10 
RNA sequencing batches as covariates;  
4) 3305-3364 genes for the unpaired analysis of intact and degraded samples; 
5) 6852-7027 genes for the unpaired analysis of intact and degraded samples, with 
19 additional covariates accounting for technical variation identified by SVAseq. 
The results agree with the higher power expected in a paired analysis compared to an 
unpaired analysis. Conservatively, we considered a gene “significantly differentially 
expressed” between low-grade and high-grade cartilage if it showed significant differential 
expression across all analysis designs and testing methods (2,557 genes). 
 
We also carried out a sensitivity analysis of differential expression using the subset of 
patients from cohort 4 only (47 patients with paired high-grade and low-grade cartilage 
samples). We included the same covariates as in the main analysis and applied the same 
analysis designs and tests for differential expression. Of the 2,557 genes with significant 
differences in the main analysis, 1,979 (77.4%) were also significant across all analysis 
designs and approaches in the sensitivity analysis. There was a high correlation of effect 
estimates between the main and sensitivity analysis. For example, in the paired analysis of 
intact and degraded samples, with 10 additional covariates accounting for technical 
variation identified by SVAseq, using limma, the Pearson correlation of log-fold-differences 
was r=0.82 across all 15,249 genes, and even higher at r=0.96 across the 2,557 genes with 
significant differences in the main analysis. 
 
 
Supplementary Note 4: Differential protein abundance between high-grade and low-grade 
cartilage 
As batch effects in proteomics data can be pervasive3,4, paired samples from any patient 
were always assayed in the same 6-plex (cohort 1) or 10-plex (cohorts 2-4). As a sensitivity 
analysis, we carried out a differential abundance analysis for the proteomics data with 
explicit adjustment for the plexes (see Methods). The results were highly similar to the main 
analysis. In particular, the correlation of protein log-fold-changes between the sensitivity 
and main analyses was very high (Pearson r=0.98 and Spearman r=0.97, both P<10-10). Of 
the 2,233 proteins with FDR<5% in the main analysis, all had a concordant direction of effect 
in the sensitivity analyses, and 1,796 (80.4%) were also significant at 5% FDR in the 
sensitivity analysis. As the low-grade and high-grade samples from the same patient were 
assayed in the same 6-plex or 10-plex, the adjustment for patient effects in the main 
analysis is expected to capture batch effects, as indeed confirmed by this sensitivity analysis. 
 
Generally, many past studies have found discrepancies between mRNA and protein levels 
due to different post-transcriptional and translational regulation and different rates of 
degradation (e.g. 5). This gives rise to different relative expression and abundance levels as 
assessed by RNA-seq and quantitative proteomics, and different technical noise for the two 
omics levels. Thus, the power to detect differences on RNA and protein level would also be 
different, and affect which differences are statistically significant at the 5% FDR level.  
Of the 4390 genes measured on both RNA and protein level, 409 genes were differentially 
expressed on both omics levels, 397 genes on RNA-level only, 1610 genes on protein-level 
only, and 1974 not on either omics level. That overlap in detected cross-omics molecular 
differences is significant (Fisher’s p-value 0.0029). 
We also found strong evidence for concordant direction of expression changes across the 
two omics levels, with a correlation of r=0.63 (P<1.0x10-17) between the RNA- and protein-
level effect sizes for genes with cross-omics changes (Supplementary Fig. 8b), providing 
internal cross-validation for the approaches used.  
 
Supplementary Note 5: Pathway associations for differences between high-grade and low-
grade cartilage 
In particular, significant associations in the Signalling Pathway Impact Analysis (SPIA) include 
the activation of the “ECM-receptor interaction” in high-grade compared to low-grade 
cartilage (identified across RNA-level, protein-level, and cross-omics DE genes), with 
activations of the “Focal adhesion”, “Lysosome”, and “Cytokine-cytokine receptor 
interaction” pathways identified based on the RNA data (Supplementary Fig. 10, 
Supplementary Data 3). 
These associations agree with enrichment analyses based on Gene Ontology (GO) terms in 
GOseq, carried out separately for genes with higher or lower expression in high-grade 
cartilage compared to low-grade cartilage. Here, we identified associations with terms 
related to “extracellular space” for genes with higher expression on RNA-level, and 
separately, protein-level, and across omics levels. Genes with higher expression on RNA-
level also showed significant associations with terms related to “plasma membrane”, 
“vesicle”, “cell adhesion”, “cell communication”, and “signaling” (Supplementary Data 3). 
Protein-level differentially expressed genes showed enrichments for “extracellular region” 
and related terms among genes with both higher and lower expression; genes with lower 
expression also showed associations with “small molecule metabolic process”, “vesicle”, 
“ECM structural constituent“, and “cofactor binding” (Supplementary Data 3). 
 
Supplementary Note 6: Candidate therapeutic compounds 
We note that one of the shortlisted oestrogen receptor agonists, alpha-estradiol, targets 
KCNMA1, coding for the pore-forming alpha subunit of a calcium-sensitive potassium 
channel that demonstrated significantly lower gene expression and protein abundance in 
high-grade cartilage. 
A conditional knock-down of Vegf attenuates surgically-induced osteoarthritis in mice, with 
intra-articular anti-VEGF antibodies as well as oral administration of the VEGFR2 kinase 
inhibitor Vandetanib suppressing osteoarthritis progression6. 
RHO-kinase-inhibitor-III[rockout] is a rho associated kinase inhibitor. In a rat model of 




DNA, RNA and protein extraction: cohort 3 
For samples from cohort 3, cells were lysed in 350µl RLT buffer containing 3.5µl b-
mercaptoethanol and centrifuged in a Qiashredder column (Qiagen) for 2 min at 20,800g. 
RNA, DNA and protein were purified using a series of column based centrifugation steps and 
RNA was eluted in 34 µl RNase-free water, DNA in 100 µl EB buffer and the protein pellet 
solubilised in 100µl 10% sodium dodecyl sulphate in PBS. DNA and RNA preparations were 
re-precipitated to remove buffer salts and to concentrate the final product: 20µl 3M sodium 
acetate, pH 5.5 (Ambion) was added per 100µl of DNA or RNA solution and mixed gently. 
Then, 283µl of molecular grade ethanol (Sigma) was added per 100µl of DNA or RNA 
solution to precipitate the nucleic acids and the mixture placed at -20°C overnight. Samples 
were centrigfuged at 20,800g for 30 minutes and the supernatant removed, the pellet was 
washed with 900µl 70% ethanol and the nucleic acids re-pelleted by spinning at 20,800g for 
10 minutes. Nucleic acids were resuspended in 32µl DNase/RNase free water. 
 
Proteomics: cohort 1 
Protein Digestion and TMT Labeling 
The protein content of each sample was precipitated by the addition of 30 μL TCA 8 M at 4 
°C for 30 min. The protein pellets were washed twice with ice cold acetone and finally re-
suspended in 40 μL 0.1 M triethylammonium bicarbonate, 0.05% SDS with pulsedprobe 
sonication. Protein concentration was measured with Quick Start Bradford Protein Assay 
(Bio-Rad) according to manufacturer’s instructions. Aliquots containing 30 μg of total 
protein were prepared for trypsin digestion. Cysteine disulfide bonds were reduced by the 
addition of 2 μL 50 mM tris-2-carboxymethyl phosphine (TCEP) followed by 1 h incubation in 
heating block at 60 °C. Cysteine residues were blocked by the addition of 1 μL 200 mM 
freshly prepared Iodoacetamide (IAA) solution and 30 min incubation at room temperature 
in dark. Trypsin (Pierce, MS grade) solution was added at a final concentration 70 ng/μL to 
each sample for overnight digestion. After proteolysis the peptide samples were diluted up 
to 100 μL with 0.1 M TEAB buffer. A 41 μL volume of anhydrous acetonitrile was added to 
each TMT 6-plex reagent (Thermo Scientific) vial and after vortex mixing the content of each 
TMT vial was transferred to each sample tube. Labeling reaction was quenched with 8 μL 5% 
hydroxylamine for 15 min after 1 h incubation at room temperature. Samples were pooled 
and the mixture was dried with speedvac concentrator and stored at -20 °C until the high-
pH Reverse Phase (RP) fractionation. 
 
Peptide fractionation  
Offline peptide fractionation based on high pH Reverse Phase (RP) chromatography was 
performed using the Waters, XBridge C18 column (2.1 x 150 mm, 3.5 μm, 120 Å) on a 
Dionex Ultimate 3000 HPLC system equipped with autosampler. Mobile phase (A) was 
composed of 0.1% ammonium hydroxide and mobile phase (B) was composed of 100% 
acetonitrile, 0.1% ammonium hydroxide. The TMT labelled peptide mixture was 
reconstituted in 100 μL mobile phase (A), centrifuged and injected for fractionation. The 
multi-step gradient elution method at 0.2 mL/min was as follows: for 5 minutes isocratic at 
5% (B), for 35 min gradient to 35% (B), gradient to 80% (B) in 5 min, isocratic for 5 minutes 
and re-equilibration to 5% (B). Signal was recorded at 280 nm and fractions were collected 
in a time dependent manner every one minute. The collected fractions were dried with 
SpeedVac concentrator and stored at -20 °C until the LC-MS analysis. 
 
LC-MS Analysis 
LC-MS analysis was performed on the Dionex Ultimate 3000 UHPLC system coupled with the 
high-resolution LTQ Orbitrap Velos mass spectrometer (Thermo Scientific). Each peptide 
fraction was reconstituted in 40 μL 0.1% formic acid and a volume of 10 μL was loaded to 
the Acclaim PepMap 100, 100 μm × 2 cm C18, 5 μm, 100 Ȧ trapping column with a user 
modified injection method at 10 μL/min flow rate. The sample was then subjected to a 
multi-step gradient elutionon the Acclaim PepMap RSLC (75 μm × 50 cm, 2 μm, 100 Å) C18 
capillary column (Dionex) retrofitted to an electrospray emitter (New Objective, FS360-20-
10-N-20-C12) at 45 °C. Mobile phase (A) was composed of 96% H2O, 4% DMSO, 0.1% formic 
acid and mobile phase (B) was composed of 80% acetonitrile, 16% H2O, 4% DMSO, 0.1% 
formic acid. The gradient separation method at flow rate 300 nL/min was as follows: for 95 
min gradient to 45% B, for 5 min up to 95% B, for 8 min isocratic at 95% B, re-equilibration 
to 5% B in 2 min, for 10 min isocratic at 5% B.  
The ten most abundant multiply charged precursors within 380 -1500 m/z were selected 
with FT mass resolution of 30,000 and isolated for HCD fragmentation with isolation width 
1.2 Th. Normalized collision energy was set at 40 and the activation time was 0.1 ms for one 
microscan. Tandem mass spectra were acquired with FT resolution of 7,500 and targeted 
precursors were dynamically excluded for further isolation and activation for 40 seconds 
with 10 ppm mass tolerance. FT max ion time for full MS experiments was set at 200 ms and 
FT MSn max ion time was set at 100 ms. The AGC target vales were 3×10e6 for full FTMS 
and 1×10e5 for MSn FTMS. The DMSO signal at m/z 401.922718 was used as a lock mass. 
 
 
Proteomics: cohorts 2-4 
Protein Digestion and TMT Labeling 
The protein content of each sample was precipitated by the addition of 30 μL TCA 8 M at 4 
°C for 30 min. The protein pellets were washed twice with ice cold acetone and finally re-
suspended in 40 μL 0.1 M triethylammonium bicarbonate, 0.1% SDS with pulsed probe 
sonication. Equal aliquots containing at least 10 μg of total protein were reduced with 5 mM 
TCEP for 1h at 60 °C, alkylated with 10 mM Iodoacetamide and subjected to overnight 
trypsin (70 ng/μL) digestion. TMT 10-plex (Thermo Scientific) labelling was performed 
according to manufacturer’s instructions at equal amounts of tryptic digests. Samples were 
pooled and the mixture was dried with speedvac concentrator and stored at -20 °C until the 
peptide fractionation.  
 
Peptide fractionation 
Offline peptide fractionation was based on high pH Reverse Phase (RP) chromatography 
using the Waters, XBridge C18 column (2.1 x 150 mm, 3.5 μm) on a Dionex Ultimate 3000 
HPLC system. Mobile phase A was 0.1% ammonium hydroxide and mobile phase B 100% 
acetonitrile, 0.1% ammonium hydroxide. The TMT labelled peptide mixture was dissolved in 
100 μL mobile phase A, centrifuged and injected for fractionation. The gradient elution 
method at 0.2 mL/min included the following steps: 5 minutes isocratic at 5% B, for 35 min 
gradient to 35% B, gradient to 80% B in 5 min, isocratic for 5 minutes and re-equilibration to 
5% B. Signal was recorded at 280 nm and fractions were collected every one minute. For 
cohort 4, peptide fractionation was performed on reversed-phase OASIS HLB cartridges at 
high pH and up to 9 fractions (10-25% acetonitrile elution steps) were collected for each set. 
The collected fractions were dried with SpeedVac concentrator and stored at -20 °C until the 
LC-MS analysis. 
 
LC-MS Analysis   
LC-MS analysis was performed on the Dionex Ultimate 3000 UHPLC system coupled with the 
Orbitrap Fusion Tribrid Mass Spectrometer (Thermo Scientific). Each peptide fraction was 
reconstituted in 40 μL 0.1% formic acid and a volume of 7 μL was loaded to the Acclaim 
PepMap 100, 100 μm × 2 cm C18, 5 μm, 100 Ȧ trapping column with the μlPickUp mode at 
10 μL/min flow rate. The sample was then analysed with a gradient elution on the Acclaim 
PepMap RSLC (75 μm × 50 cm, 2 μm, 100 Å) C18 capillary column retrofitted to an 
electrospray emitter (New Objective, FS360-20-10-D-20) at 45 °C. Mobile phase A was 0.1% 
formic acid and mobile phase B was 80% acetonitrile, 0.1% formic acid. The gradient 
method at flow rate 300 nL/min was: for 90 min gradient to 38% B, for 5 min up to 95% B, 
for 13 min isocratic at 95% B, re-equilibration to 5% B in 2 min, for 10 min isocratic at 10% B. 
Precursors were selected with 120k mass resolution, AGC 3×105 and IT 100 ms in the top 
speed mode within 3 sec and were targeted for CID fragmentation with quadrupole 
isolation width 1.2 Th. Collision energy was set at 35% with AGC 1×104 and IT 35 ms. MS3 
quantification spectra were acquired with further HCD fragmentation of the top 10 most 
abundant CID fragments isolated with Synchronous Precursor Selection (SPS) excluding 
neutral losses of maximum m/z 18. Iontrap isolation width was set at 0.7 Th for MS1 
isolation, collision energy was applied at 55% and the AGC setting was at 6×104 with 100 ms 
IT. The HCD MS3 spectra were acquired within 110-400 m/z with 60k resolution. Targeted 
precursors were dynamically excluded for further isolation and activation for 45 seconds 
with 7 ppm mass tolerance. Cohort 4 were analyzed at the MS2 level with a top15 HCD 
method (CE 40%, 50k resolution) and a maximum precursor intensity threshold of 5×107 
using the same MS1 parameters as above in a 360 min gradient. 
 
Heatmaps of molecular differences between high-grade and low-grade cartilage 
We used the pheatmap v1.0.12 function in R to plot heatmaps of gene expression and 
protein abundance values. Among the 290 genes with significant and concordant cross-
omics differences, we selected the top 20 genes and top 20 proteins with the highest 
absolute log-fold-differences between high-grade and low-grade cartilage. For gene 
expression, this was based on the paired-sample analysis with limma including the 10 
technical covariates inferred by SVseq. Analogously to the differential gene expression and 
protein abundance analysis, we then regressed out patient-level effects and 10 technical 
covariates for gene expression, and the patient-level effects for the protein abundance (as 




Supplementary Figure 1. Large-scale multi-omics characterisation of osteoarthritis disease 
tissue: number of patients with data for each tissue and omics type after quality control. 




Supplementary Figure 2. cis-eQTLs in osteoarthritis disease tissue. 
a, High correlation of eQTL normalized effect sizes (NES) between low-grade and high-
grade cartilage. Inset: Spearman correlation between NES effect sizes across all 
eQTLs. The direction of effect was concordant across all cis-eQTLs detected in both 
low- and high-grade cartilage (92,758 variant-gene pairs). 
b, High correlation of eQTL normalized effect sizes (NES) between low-grade cartilage 
and synovium (left), and between high-grade cartilage and synovium (right). Inset: 
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Supplementary Figure 3. cis-pQTLs in osteoarthritis disease tissue. 
a, pQTL overlap between tissues, for a total of 38 genes with a least one pQTL (left) and 
3,211 pQTL protein-variant pairs (right). 
b, High correlation of pQTL NES between low-grade and high-grade cartilage. Inset: 
Spearman correlation between NES effect sizes across all eQTLs.  
c, An example of a pQTL effect for ALDH1A2, for which we detected colocalisation of 
GWAS association and pQTL effect in low-grade cartilage. Genotype-dependent 
protein abundance for the GWAS index variant is displayed. The boxplots show 
expression (residuals after regressing the normalised expression data on the 15 PEER 
factors, sex and array) at 25th to 75th percentiles, with centre at the median and 
whiskers extend to 1.5 times the interquartile range. NES: FastQTL normalised effect 
a
High-grade cartilage High-grade cartilageLow-grade cartilage Low-grade cartilage
b
!=0.94
Genes with pQTLs pQTL variants
size; P: FastQTL association P-value, n: number of individuals included in the analysis 
for each genotype. 
d, Correlation of pQTL NES and eQTL NES in high-grade and low-grade cartilage 
  
 
Supplementary Figure 4. Protein-protein interaction network for 38 proteins with pQTLs 
detected in cartilage (STRING v11.0).  
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Supplementary Figure 5. Genes with molecular QTL present in high-grade, but not low-
grade cartilage (posterior probability m>0.9 and m<0.1, respectively). 
For each of the 23 genes, the variant with strongest differential eQTL signal is shown. The 
boxplots show expression (residuals after regressing the normalised expression data on the 
15 PEER factors, sex and array) at 25th to 75th percentiles, with centre at the median and 
whiskers extend to 1.5 times the interquartile range. n: number of individuals included in 



















Supplementary Figure 6. Genes with molecular QTL present in low-grade, but not high-
grade cartilage (posterior probability m>0.9 and m<0.1, respectively). 
For each of the 9 genes, the variant with strongest differential eQTL signal is shown. The 
boxplots show expression (residuals after regressing the normalised expression data on the 
15 PEER factors, sex and array) at 25th to 75th percentiles, with centre at the median and 
whiskers extend to 1.5 times the interquartile range. n: number of individuals included in 
the analysis for each genotype. 
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Supplementary Figure 7. Co-localisation of osteoarthritis GWAS signals and low-grade 
cartilage cis-eQTLs for NPC1 and SMAD3. 
The plots show GWAS and low-grade cartilage eQTL p-values for regions surrounding  
a, GWAS signal with index variant rs10502437 and NCP1 eQTLs in low-grade cartilage 
b, GWAS signal with index variant rs12901372 and SLC44A2 eQTLs in low-grade cartilage.  
For both GWAS signals, we observed colocalisation with eQTLs in both low-grade and high-
grade cartilage, and the plots for high-grade cartilage are shown in Fig. 3. Each plot shows 
1Mb region centered around the GWAS index SNP (purple); each point represents a genetic 
variant. Top panels show GWAS p-values, bottom panels QTL p-values for the indicated 
gene. Here and in Fig. 3, LD between variants was calculated using UK Biobank. PP4: 
posterior probability for colocalisation. 
  
a                                                                                  b             
 
Supplementary Figure 8. Molecular differences between high-grade and low-grade 
cartilage. 
a, Wide-spread RNA-level (left) and protein-level (right) differences between high-
grade and low-grade cartilage. The RNA plot shows conservative results based on 
different approaches (see Methods), with 2,557 differentially expressed genes 
significant at 5% FDR in all approaches.  
b, RNA- and protein-level log-fold differences for 409 genes with significant cross-omics 
differences between high-grade and low-grade cartilage (see panel C for all genes). 
The direction of difference agrees for 290 of the 409 genes (71%; binomial P<1.0x10-
17), with a strong correlation of effect sizes (Pearson r=0.63, P<10-10). 













































































































































































































































































































































































Correlation of cross-omics effects
n=70 n=148
n=142 n=49
High-grade versus low-grade cartilage:
Signalling Pathway Impact Analysis
Minimum log-fold-difference
RNA log-fold-difference 
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c, RNA- and protein-level log-fold-differences for all genes measured on both omics 
levels. The x-axis shows gene expression differences between low-grade and high-
grade cartilage as quantified by limma in an analysis including the technical 
covariates as identified by pSVA as well as pairing samples from the same patients. 
The genes highlighted black or red were significant on both RNA- and protein-level, 
see also (B). The correlation of effect sizes across all genes was also significant 




Supplementary Figure 9. Heatmap of gene expression (a) and protein abundance (b) for 
top 20 genes respectively proteins with highest absolute log-fold-differences between 
high-grade and low-grade cartilage, among all genes with cross-omics significant and 
concordant differences. 
a, Gene expression residuals after regressing out patient-level effects and 10 additional 
covariates accounting for technical variation (as identified by SVAseq and used in 
differential gene expression analysis). The 20 genes were selected based on log-fold-
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differences quantified by limma from the paired-sample analysis including 10 
technical covariates. 
b, Protein abundance residuals after regressing out patient-level effects from quantile 
normalised data used for differential abundance analysis. Grey colour indicates 
proteins not quantified in a given sample. 
  
 
Supplementary Figure 10. Biological pathways and processed associated with molecular 
differences between high-grade and low-grade cartilage. 
a, Signalling Pathway Impact Analysis (SPIA) identified biological pathways associated 
with differences between high-grade and low-grade cartilage. Pathways with 
significant results at 5% FDR based on RNA-level changes are shown, all activated in 
high-grade cartilage. Boxes on the outside circles represent individual genes, with 
arches connecting the same gene across pathways.  
b, Signalling Pathway Impact Analysis (SPIA) p-values for pathways that show significant 
association with differences between high-grade and low-grade cartilage based on 
RNA-level changes. Enrichment p: p-value from over-representation analysis of 
genes; Perturbation p: p-value for perturbation of the pathway based on gene log-
fold-differences; Combined p: p-value from combining enrichment and perturbation 
p-values. Pathways with significant results at 5% FDR based on RNA-level changes 
are shown. See also full results in Supplementary Data 3. 
  
a
High-grade versus low-grade cartilage:
Signalling Pathway Impact Analysis




















































































Lower expression in 
high-grade cartilage
Higher expression in 
high-grade cartilage
b
Data available online 
 
Raw data: uploaded to EGA/PRIDE (accession numbers see Data availability statement) 
1. RNA sequencing data [EGA] 
2. Proteomics data [PRIDE] 
3. Genotype data [EGA] 
 
Data uploaded to https://hmgubox.helmholtz-muenchen.de/d/fc1fcf65a6724152b7f9/  
Significant molQTLs 
4. Significant cis-eQTLs for high-grade and low-grade cartilage 
5. Significant cis-pQTLs for high-grade and low-grade cartilage 
 
TSS data 
6. TSS for each gene  
 
Full colocalisation results (probabilities for each locus, tissue, and omics level) 




1. Robins, C., et al. Genetic control of the human brain proteome. bioRxiv, 816652 
(2019). 
2. Szklarczyk, D., et al. STRING v11: protein-protein association networks with 
increased coverage, supporting functional discovery in genome-wide experimental 
datasets. Nucleic Acids Res 47, D607-D613 (2019). 
3. Gregori, J., et al. Batch effects correction improves the sensitivity of significance 
tests in spectral counting-based comparative discovery proteomics. J. Proteom. 75, 
3938-3951 (2012). 
4. Kuligowski, J., et al. Detection of batch effects in liquid chromatography-mass 
spectrometry metabolomic data using guided principal component analysis. Talanta 
130, 442-448 (2014). 
5. Fortelny, N., Overall, C.M., Pavlidis, P. & Freue, G.V.C. Can we predict protein from 
mRNA levels? Nature 547, E19-e20 (2017). 
6. Nagao, M., et al. Vascular endothelial growth factor in cartilage development and 
osteoarthritis. Sci. Rep. 7, 13027 (2017). 
7. Takeshita, N., et al. Alleviating effects of AS1892802, a rho kinase inhibitor, on 
osteoarthritic disorders in rodents. J. Pharmacol. Sci. 115, 481-489 (2011). 
 
